Synopsis

A -- STATISTICAL SUPPORT SERVICES FOR ASSESSING AIR QUALITY DATA AND APPLICATIONS. SOL PR-NC-09-10467 DUE 032210 POC ANNA L. MUSTARD, Contract Specilist, Phone: (919) 541-4556, E-Mail: mustard.anna@epa.gov WEB: FBO.gov Permalink https://www.fbo.gov/spg/EPA/OAM/CMD/PR-NC-09-10467/listing.html E-MAIL: ANNA L. MUSTARD mustard.anna@epa.gov NAICS: 541712 The U. S. Environmental Protection Agency intends to award a contract for Statistical Support Services for Assessing Air Quality Data and Applications. These services are required by the Atmospheric Modeling and Analysis Division (AMAD) within the U. S. EPA?s Office of Research and Development (ORD). This acquisition is being offered as a Total Small Business Set Aside, with a North American Industry Classification System (NAICS) code of 541712. The Small Business Administration (SBA) size standard for NAICS code 541712 is 500 employees. AMAD leads the development and evaluation of predictive atmospheric models for assessing changes in air quality and air pollutant exposures in support of EPA's mission to protect human health and the environment. The models developed by AMAD are being used by EPA, NOAA, and the air pollution community in understanding and forecasting not only the magnitude of the air pollution problem but also in developing emission control policies and regulations for air quality improvements. AMAD also conducts research to link air quality modeling tools with human exposure and health outcomes. Exposure from ambient pollutants occurs at local (e.g., near-roadways) and regional scales (e.g., transported pollution). Thus, this research provides analytical and physical modeling approaches that provide the spatial and temporal detail of concentration surfaces needed to understand the relationships among pollutants emitted, the resultingair quality, and exposure of humans to these pollutants. The contractor shall provide statistical support services in pursuit of these objectives in two major areas: (1) generating and improving air quality surfaces for use at various scales; and, (2) evaluating simulated products. Efforts required under this contractshall include the following: improving air quality and related data through statistical approaches such as fusing air quality data and conducting quality assurance of air quality data; analyzing and characterizing air quality and related data through descriptive statistics and assessing temporal and spatial trends andrelationships among emissions, ambient concentrations, exposure and health outcomes; and, developing and applying statistical techniques to evaluate models andtools. Award of an indefinite delivery, indefinite quantity (IDIQ) contract is anticipated. The resulting contract is expected to have a base year and four one-year option periods. The Request For Proposal (RFP) will be issued approximately 15 days after the date of publication of this notice, with proposals due approximately thirty (30) days after release of the RFP/solicitation. The RFP will beavailable solely through the EPA?s website at http://www.epa.gov/oam/rtp_cmd. Hard copies of the solicitation document will not be available. All future information about this acquisition, including amendments (if any), will also be distributed solely through the EPA?s web site. Interested parties are responsible for monitoring this site to ensure that they have the most up-to-date information about this acquisition. Telephone and FAX requests will not be honored. All prospective offerors must be actively registered in the Central Contractor Registration (CCR) site at www.ccr.gov. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=415dcdbe7f1eba143eae9d85f42c1356&tab=core&_cview=0 Posted 02/11/10 (W-SN02064259). (0042)

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after February 22, 2010. The deadline for receipt of optional letters of intent is February 22, 2010. The deadline for receipt of full applications is March 22, 2010.

Synopsis

This NIH Funding Opportunity Announcement (FOA), supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, invites applications from U.S. institutions for one year of support for resources and activities that will strengthen oversight of NIH supported human subjects research conducted collaboratively with institutions in low- to middle-income countries (LMIC). This FOA will utilize the NIH Biomedical Research Support Grants (S07) mechanism.

Deadline Note

An applicant is eligible to apply even if no letter of intent is submitted. This letter should be sent by March 22, 2010. The due date for applications under this grant announcement is April 5, 2010.

Synopsis

The Hepatitis C Treatment Expansion Initiative will award funds for up to two years to support organizations funded under the Ryan White Program to implement and evaluate interventions designed to provide Hepatitis C (HCV) treatment in the context of Ryan White-funded HIV primary care.

Deadline Note

An applicant is eligible to apply even if no letter of intent is submitted. This letter should be sent by March 22, 2010. The due date for applications under this announcement is April 5, 2010.

Synopsis

The Maternal and Child Health Research Program will award a cooperative agreement for the following purpose: Research Network on Pregnancy-Related Care that promotes coordinated research activities that focus on studying the content of provider practice and risk reduction practices related to pregnancy care and translation of research to practice. These network activities should result in health and health services improvements in critical MCH areas such as low birth weight and preterm births.

Synopsis

The sponsor announces the availability of funding and requests applications for the Tribal College Equity Program (TCEG) for FY 2010 to enhance educational opportunities for Native Americans by strengthening instructional programs in the food and agricultural sciences. NIFA anticipates the amount available for support of this program in FY 2010 will be approximately $3,000,000.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after February 22, 2010. The deadline for receipt of full applications is March 22, 2010. This FOA will expire on Mach 23, 2010.

Synopsis

The sponsor invites pre-applications for The NIDA Translational Avant-Garde Award. The NIDA Translational Avant-Garde Award is designed to support dedicated and talented basic and/or clinical researchers with the vision, drive and expertise necessary to translate research discoveries into medications for the treatment of diseases of addiction. Through this FOA, the National Institute on Drug Abuse (NIDA) is committed to making significant advances in the development of safe and efficacious products for the treatment of disorders stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use or abuse. This announcement will utilize the X02 mechanism for submission and consideration of pre-applications. The X02 pre-application is a first step in applying for a Translational Avant-Garde Award. No awards will be made under this announcement. Through the associated FOA (RFA-DA-10-013, SPIN Program # 07799), NIDA expects to commit approximately $ 2 million per year for 5 years to fund 2-3 awards.

Synopsis

The sponsor is seeking applications from qualified Non-Governmental Organizations (NGO) including educational institutions for a five year program to implement and manage a project to increase the availability of social sector services and related products primarily through the private sector. A cooperative agreement will be used to implement this program. This type of instrument was chosen because USAID (1) desires to achieve a public purpose of support – to increase the availability of social sector services in Zimbabwe and (2) expects to be substantially involved in the implementation of this program.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after February 23, 2010. The deadline for receipt of full applications is March 23, 2010.

Synopsis

The sponsor invites applications that propose to develop, enhance, and validate translational tools to facilitate rigorous study of complementary and alternative medicine (CAM) approaches that are in wide use by the public. Recent data from the National Health Interview Survey [http://www.cdc.gov/nchs/nhis.htm] establish that Americans are utilizing CAM approaches to promote health and well-being, to treat or prevent disease, and for symptom relief. CAM approaches being widely used include massage and manipulative therapies, meditation, yoga, non-vitamin/non-mineral natural products, and acupuncture with chronic pain, back pain and musculoskeletal pain being the most commonly cited reasons for their use. This FOA focuses on encouraging the development of improved research methodology to study safety, efficacy, and clinical effectiveness of mind-body interventions (such as meditation), manual therapies, and/or yoga therapy. This FOA will use the NIH Research Project (R01) award mechanism.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after February 23, 2010. This program will expire on March 24, 2010.

Synopsis

The sponsor provides support to purchase or upgrade commercially available instruments that cost at least $100,000. The maximum award is $500,000. This program will use the NIH S10 award mechanism.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after February 24, 2010. The deadline for receipt of full applications is March 24, 2010.

Synopsis

This AHRQ Funding Opportunity Announcement (FOA), supported by funds provided to AHRQ under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, invites applications to promote the increased implementation and widespread use of findings from comparative effectiveness research (CER) that have been demonstrated to improve the prevention, diagnosis, management or treatment of a clinical condition or to otherwise improve care quality, improve access to care, reduce disparities, or improve population-based measures of health outcomes. For purposes of this FOA, the scope of CER findings includes not only clinical findings but also findings on the effectiveness of implementation approaches, including “behavioral change and delivery system strategies,” as spelled out in the Federal Coordinating Council recommendations and Institute of Medicine (IOM) recommendations. This FOA also reflects HHS recognition that, for the CER enterprise to be successful, funds must be directed at accelerating the dissemination and translation of CER findings into health care practice improvement. To achieve maximum impact, applicants will leverage broad-based, multi-stakeholder or multi-site collaborations or partnerships to develop and implement comprehensive initiatives composed of one or more interventions and strategies. This FOA will use the AHRQ Research Demonstration and Dissemination Projects (R18) grant mechanism.

Deadline Note

The Grants.gov due date is March 24, 2010. The EHB's due date is April 9, 2010.

Synopsis

Through the Recovery Act, the sponsor is making funds available to increase the Nation's ability to address the shortages of health care practitioners.

Deadline Note

The Grants.gov due date is March 24, 2010. The EHB's due date is April 9, 2010.

Synopsis

Through the Recovery Act, the sponsor is making funds available to increase the Nation's ability to address the shortages of health care practitioners.

Deadline Note

The Grants.gov due date is March 24, 2010. The EHB's due date is April 9, 2010.

Synopsis

Through the Recovery Act, the sponsor is making funds available to increase the Nation's ability to address the shortages of health care practitioners.

Deadline Note

The Grants.gov due date is March 24, 2010. The EHB's due date is April 9, 2010.

Synopsis

Through the Recovery Act, the sponsor is making funds available to increase the Nation's ability to address the shortages of health care practitioners.

Deadline Note

The Grants.gov due date is March 24, 2010. The EHB's due date is April 9, 2010.

Synopsis

Through the Recovery Act, the sponsor is making funds available to increase the Nation's ability to address the shortages of health care practitioners.

Deadline Note

The Grants.gov due date is March 24, 2010. The EHB's due date is April 9, 2010.

Synopsis

Through the Recovery Act, the sponsor is making funds available to increase the Nation's ability to address the shortages of health care practitioners.

Deadline Note

Pre-applications are required and must be received by March 24, 2010. The deadline for full proposals is April 7, 2010.

Synopsis

The Postdoctoral Award enables recent medical or other doctoral degree graduates to obtain the necessary experience to pursue an independent career in breast cancer research. Candidates for this award should exhibit a strong desire to pursue a career in breast cancer research. The Office of the Congressionally Directed Medical Research Programs (CDMRP) expects to allot approximately $8.1M of the $150M FY10 BCRP appropriation to fund approximately 25 Postdoctoral Fellowship Award applications, depending on the quality and number of applications received.

Synopsis

The sponsor provides $100,000 for defense-related cooperative research and development projects to be conducted jointly by a small business awardee and a nonprofit or federally-funded research institution. Phase I project periods cannot exceed six months.

Deadline Note

The preapplication deadline is 5:00 p.m. Eastern time, March 24, 2010. Selected applicants will be invited to submit a full proposal. If invited, full proposals are due 11:59 p.m. Eastern time, April 7, 2010.

Synopsis

The Breast Cancer Research Program (BCRP) Innovator Award supports visionary individuals who have a history of creativity, innovative work, and leadership in any field including, but not limited to, breast cancer. The Innovator Award will provide these individuals with the funding and freedom to pursue their most novel, visionary, high-risk ideas that could ultimately lead to the eradication of breast cancer.

Deadline Note

Pre-applications must be received by 5:00 p.m. Eastern time, March 24, 2010. The sponsor will invite selected applicants to submit full proposals. If invited, full proposals must be received by 11:59 p.m. Eastern time, April 7, 2010.

Synopsis

The intent of the Era of Hope Scholar Award is to recognize individuals who have high potential for innovation in breast cancer research early in their careers. Candidates for this award should be exceptionally talented, early-career scientists who have demonstrated that they are the “best and brightest” in their field(s) through their extraordinary creativity, vision, and productivity. They also should exhibit strong potential for leadership in the breast cancer research community and be able to articulate a vision for the eradication of breast cancer. These individuals should challenge current dogma and demonstrate an ability to look beyond tradition and convention. Award recipients will be expected to challenge the status quo through creative, high-risk research that ultimately may lead to the eradication of breast cancer. This award will support these emerging innovators as they implement their visions and take on leadership roles in the breast cancer research community. Applicants must be nominated to be considered for this award mechanism. Self-nominations will not be accepted.

Synopsis

R -- SUBSTANCE USE DISORDER SERVICES (SUDS) TRANSITIONAL HOUSING SOLVA-256-10-RP-0134 DUE 032410 POC Teresa A CochranContract Specialist WEB: FBO.gov Permalink https://www.fbo.gov/spg/VA/ShVAMC/VAMCLAOBrooks/VA-256-10-RP-0134/listing.html E-MAIL: Contract Specialist teresa.cochran@va.gov NAICS: 623990 Thisnotice is to serve as a pre-solicitation notice for an upcoming solicitation for Substance Use Disorder Services (SUDS) transitional/residential housing services. Contractor will provide room, board, transportation and other SUDS treatmentsupportive services to patients enrolled in SUDS and deemed eligible for such services as determined by the medical center director or his designee. Services will be furnished to beneficiaries for whom such care is specifically authorized by the Department of Veterans Affairs (DVA). Services will include, but not be limited to, provision of an alcohol and drug free environment, facilitation of active affiliation with Alcoholics Anonymous/Narcotics Anonymous programs, supportive social activities, and individual counseling as required to facilitate overcoming resistance to engagement in DVA treatment or rehabilitative services. It is further understood that beneficiaries receiving services under this contract will be provided access to basic health and hygiene maintenance opportunities, monitoring of medication compliance, appliances and materials for laundry needs and any other service or supplies without additional charge. Two hot meals and a sack lunch will be provided daily Monday through Friday for patients enrolled in Ambulatory Detoxification and Intensive Outpatient Rehabilitation. Meals provided on weekends will be of equal quantity and quality. Evening and weekend transitional housing activities such as transportation to attend at AA/NA meetings willbe provided (no less than 5 outside AA/NA meetings per week). Medications will be secured and patient self administration of medication will be supervised withthe supervisor maintaining written records medications observed as taken by patients. The Contractor shall provide transportation of rehabilitation and detoxification patients to and/or from the Overton Brooks VA medical Center, including the Medical Center Acute Care/Emergency Department, 24 hours a day 7 days a week. A qualified contractor must be capable of warranting that all applicable fire laws are complied with and that there are no outstanding recommendations of fireofficials which have not been resolved. The contractor shall have the capability to house a minimum of 12 patients from the date of contract award and shall within 120 days of contract award have the capability to house a maximum of 24 patients. Your response to the request for proposal must contain all requested pricing and non pricing information (technical and past performance). The contract awarded will be for a six month base period and four one year option periods. TheNAICS code for this procurement is 623990 Other Residential Care Facilities andthe size standard is $7.0 million. The actual solicitation will be posted on orafter March 10, 2010 under solicitation number VA-256-10-RP-0134 and will contain the detailed requirements for this acquisition. Once you have read the solicitation document, questions should be submitted by email to teresa.cochran@va.gov. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=7555fd5045da26959d1dec2f334e8ebf&tab=core&_cview=0 Posted 02/23/10 (W-SN02072325). (0054)

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after February 24, 2010. The deadline for receipt of optional letters of intent is February 24, 2010. The deadline for receipt of full applications is March 24, 2010.

Synopsis

The sponsor invites applications to investigate the mechanisms of latency and the reactivation of tuberculosis in the host using integrated systems biology approaches. Systems biology is defined in many ways. For the purposes of this FOA we are using a definition found on the MIT CSBi website: “…research program that links biologists, computer scientists, and engineers in a multi-disciplinary approach to the systematic analysis of complex biological phenomena.” The studies should include multiscale computational modeling and focus on host lung responses to Mycobacterium tuberculosis (Mtb) and host-microbial interactions that drive latency and reactivation in humans. To build the theoretical models, human and animal data should be utilized. The studies should integrate the data obtained from “omic” approaches with biological/immunological data. The models should be such that they can be tested in humans or non-human primates. The use of human samples and or data is required. Applicants are strongly encouraged to use the multiple principal investigator mechanism to facilitate collaborations among investigators with expertise in mathematics and computational multiscale modeling and clinical investigators and experimental biologists who have expertise in tuberculosis, pulmonology, lung biology, immunology, microbiology, genomics, genetics, other “omics,” and infectious diseases. Applicants are also strongly urged to include bioengineers and physicists in the research groups to enable teams of investigators to take advantage of new and developing technologies likely to be needed both to obtain biological data for building the computational models and for testing hypotheses generated by them. This FOA will use the NIH Research Project (R01) award mechanism.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after February 24, 2010. The deadline for receipt of optional letters of intent is February 24, 2010. The deadline for receipt of full applications is March 24, 2010.

Synopsis

The sponsor invites applications to participate as Data Coordinating Center for the NHLBI Systems Biology Approach to the Mechanisms of Tuberculosis (TB) Latency and Reactivation program. The NHLBI Systems Biology Approach to TB Program will include multiple TB Systems Biology Centers and one Data Coordinating Center. This program is designed to investigate the mechanisms of latency and the reactivation of tuberculosis in the host using integrated systems biology approaches. Systems biology is defined in many ways. For the purposes of this FOA we are using a definition found on the MIT CSBi website a “…research program that links biologists, computer scientists, and engineers in a multi disciplinary approach to the systematic analysis of complex biological phenomena.” The studies should include multiscale computational modeling and focus on host lung responses to Mycobacterium tuberculosis (Mtb) and host-microbial interactions that drive latency and reactivation in humans. To build the theoretical models human and animal data should be utilized. The studies should integrate the data obtained from “omic” approaches with biological/immunological data. The models should be such that they can be tested in humans or non-human primates. The use of human samples and or data is required. However, the additional use of animal models/data in building and testing the models is encouraged to enable a better understanding of latency and reactivation in humans. This FOA will use the NIH Research Project (R01) award mechanism.

Deadline Note

The deadlines for receipt of optional letters of intent are February 24, 2010 and October 4, 2010. The deadlines for receipt of full applications are March 4,2010 and November 3, 2010. This program will expire on March 25, 2011.

Synopsis

The sponsor provides support to enable strong investigative teams to do inter- and/or trans-disciplinary research on a complex problem in biomedical science relevant to Diabetes, Endocrinology and Metabolic Diseases. This FOA will use the NIH Research Resource Grant Mechanism (R24).

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after February 24, 2010. The deadline for receipt of optional letters of intent is February 24, 2010. The deadline for receipt of full applications is March 24, 2010.

Synopsis

The sponsors invite applications to participate in the NIH Blueprint for Neuroscience Research. The goal of this FOA is to encourage and prepare undergraduate students from diverse backgrounds to enter Ph.D. degree programs in the neurosciences. To accomplish this goal, this initiative will provide institutional awards to develop neuroscience research education programs consisting of collaborative partnerships integrated across different educational institutions. Each collaborative research education partnership must have the following components: a) a research-intensive institution that has an established neuroscience or neuroscience related program, b) institution(s) that have a substantial enrollment of undergraduates from groups underrepresented in the biomedical and behavioral sciences, c) integrated curriculum/academic enhancement and research training activities designed to increase participants preparation to enter doctoral programs in the neurosciences, and d) well-described plans to provide early communication and interaction between participating students and graduate neuroscience programs across the country. This FOA will use the NIH Research Education (R25) award mechanism.

Deadline Note

The deadline for receipt of optional letters of intent is February 25, 2010. The deadline for receipt of full applications is March 25, 2010.

Synopsis

(br> The sponsor solicits applications from organizations that propose to develop a specialized center (P50 grant mechanism) to carry out community-based participatory research on the use of communication and information focused technologies (IT) on improving the health status of, and health-related services provided to, older adults and to focus on applied research with the objective of developing sustainable and reproducible strategies to translate research into practice effectively and efficiently. This initiative will support a broad, integrated, multidisciplinary, multi-project health services research program -- a center of excellence -- that will bring together strong teams of experienced and new researchers. The initiative has three broad strategic themes: 1) the use of IT to extend independence and functioning and reduce unnecessary health care utilization by older adults; 2) the use of IT to place the individual and families at the center of expanded and more efficient service delivery networks; and 3) the development of innovative approaches to translate evidence generated in the first two thematic areas into practice. Research results are intended to enhance the independence and functionality of older adults through applied research, development of tools, conduct of demonstration projects, educational program development and implementation, and dissemination of results. This FOA will use the P50 Specialized Center grant mechanism.

Deadline Note

Proposal submission is a two-step process consisting of a pre-application and application. The pre-application submission deadline is March 25, 2010. The application submission deadline is April 8, 2010.

Synopsis

The objectives of the BMFRP are to fund scientifically meritorious research focused on BMF syndromes and their long-term sequelae. Studies that primarily focus on myeloproliferative neoplasms, leukemia, or other malignancies are discouraged. However, studies investigating BMF syndromes and their progression to other malignancies such as leukemia are acceptable. Proposals involving therapeutics, including but not limited to bone marrow transplantation, are strongly encouraged to address issues unique to BMF syndromes. The vision of the FY10 BMFRP is to understand and cure BMF disease. Toward that end, the program challenges the scientific community to design innovative research that will advance the understanding of inherited and acquired BMF diseases to improve the health and life of individuals living with these diseases, with the ultimate goals of prevention and/or cure. The sponsor expects to allot approximately $900,000 of the $3.75M FY10 BMFRP appropriation to fund approximately 6 Exploration – Hypothesis Development Award applications, depending on the quality and number of applications received.

Deadline Note

Pre-applications are required and must be submitted by 5:00 p.m. Eastern time, March 25, 2010. Full applications must be submitted by 11:59 p.m. Eastern time, April 8, 2010.

Synopsis

The vision of the FY10 PRMRP is to identify and fund the best medical research to protect and support warfighters, veterans, and all beneficiaries, and to eradicate diseases that impact these populations. The PRMRP challenges the scientific and clinical communities to address one of the FY10 congressionally directed topic areas with original ideas that foster new directions in basic science and translational research; novel product development leading to improved therapeutic or diagnostic tools, or improvements in clinical policies/guidelines; or clinical trials that address an immediate clinical need. The PRMRP seeks applications in laboratory, clinical, behavioral, and epidemiologic research as well as public health and policy; environmental sciences; nursing; occupational health; alternative therapies; ethics; economics; and strategic research, such as studies designed to shape the development of or to validate clinical policy or guidance. Interdisciplinary and integrative health approaches are welcomed.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after February 25, 2010. The deadline for receipt of full applications is March 25, 2010.

Synopsis

The sponsors invite applications from research-intensive institutions to support mentored career development in support of comparative effectiveness research (CER) in an interdisciplinary environment catering to the needs of diverse populations of scholars including (but not limited to) those with backgrounds in biostatistics, epidemiology, health economics, pharmacology, medicine, and dentistry. Scholars should be encouraged to register for higher degrees, where appropriate. Successful applicant institutions will be expected to include course development work in their proposal and make provision for expanding the pool of experienced CER mentors. This FOA will use the ARRA-specific NIH mechanism KM1 with funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5.

Deadline Note

The deadline for receipt of expressions of interest is 25 March 2010. Full applications, if invited, will be accepted between 28 May 2010 and 9 July 2010. For international applicants, expressions of interest are open until 30 July 2010.

Synopsis

The Australia Fellowship is an award to support the salary and research of outstanding researchers with a vision to expand the scale and scope of Australian health and medical research. Australia Fellows will be conducting innovative research at the highest international levels.

Deadline Note

The deadline for receipt of optional letters of intent is February 16, 2010. The deadline for receipt of full applications is March 25, 2010.

Synopsis

The sponsor invites investigators and United States institutions/organizations with relevant active NIH-supported small business research project grants (STTR [R41, R42], SBIR [R43, R44], and SBIR/STTR Fast-Track grants) to submit competitive revision applications (formerly termed competitive supplements) to accelerate innovation through basic behavioral and social science research (b-BSSR) and development that has commercial potential and is relevant to the mission of OppNet (http://www.oppnet.nih.gov). Competitive revisions must focus on b-BSSR that has the potential to accelerate results (e.g., products, processes or services) and/or includes innovative research tools, techniques, devices, inventions, or methodologies. Competitive revision applications must support a significant expansion of the scope or research protocol approved and funded for the “parent” small business award on which the revision application is based. Support for these revision applications will come from funds provided to NIH through the American Recovery and Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5. Consistent with the Recovery Act’s intent to promote job creation and economic development along with accelerating the pace and achievement of scientific research, the purpose of this OppNet announcement is to fund supplemental b-BSSR that can inform the development of products whose marketable value is increased by b-BSSR results.

Deadline Note

Applicants are requested, but not required, to submit a letter of intent to apply for this funding opportunity. The deadline for submission of the letter of intent is March 26, 2010. The deadline for submission of applications under this Program Announcement is April 26, 2010.

Synopsis

The sponsor will hold a competition for a new cooperative agreement to operate a national information and counseling service for persons with ADRD, their family members and informal caregivers (National Alzheimer’s Call Center).

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after February 26, 2010. The deadline for receipt of full applications is March 26, 2010.

Synopsis

The sponsor is interested in funding a diverse set of projects that develop, test and evaluate various simulation approaches for the purpose of improving the safe delivery of health care. Simulation in health care predominately is a training technique that exposes individuals and teams to realistic clinical challenges through the use of mannequins, task trainers, virtual reality, or standardized patients, and allows participants to experience in real-time the consequences of their decisions and actions. The principal advantage of simulation is that it provides a safe environment for health care practitioners to acquire valuable experience without putting patients at risk. Simulation also can be used as a test-bed to improve clinical processes and to identify failure modes or other areas of concern in new procedures and technologies that might otherwise be unanticipated and serve as threats to patient safety. Applications that address a variety of clinical settings are sought. This FOA will utilize the AHRQ Research Demonstration and Dissemination Projects (R18) award mechanism.

Synopsis

The sponsor is announcing the availability of funds to support multiple programs in the purchase of health professions training equipment.

Synopsis

The sponsor is announcing the availability of funds to support multiple programs in the purchase of health professions training equipment.

Synopsis

The sponsor is announcing the availability of funds to support multiple programs in the purchase of health professions training equipment.

Synopsis

The sponsor is announcing the availability of funds to support multiple programs in the purchase of health professions training equipment.

Synopsis

The sponsor is announcing the availability of funds to support multiple programs in the purchase of health professions training equipment.

Synopsis

The sponsor is announcing the availability of funds to support multiple programs in the purchase of health professions training equipment.

Synopsis

The sponsor is announcing the availability of funds to support multiple programs in the purchase of health professions training equipment.

Deadline Note

The application due date in Grants.gov is March 26, 2010. The supplemental information due date in EHB's is April 26, 2010.

Synopsis

The sponsor is announcing the availability of funds to support multiple programs in the purchase of health professions training equipment.

Deadline Note

The application due date in Grants.gov is March 26, 2010. The supplemental information due date in EHB's is April 26, 2010.

Synopsis

The sponsor is announcing the availability of funds to support multiple programs in the purchase of health professions training equipment.

Deadline Note

The application due date in Grants.gov is March 26, 2010. The supplemental information due date in EHB's is April 26, 2010.

Synopsis

The sponsor is announcing the availability of funds to support multiple programs in the purchase of health professions training equipment.

Deadline Note

The application due date in Grants.gov is March 26, 2010. The supplemental information due date in EHB's is April 26, 2010.

Synopsis

The sponsor is announcing the availability of funds to support multiple programs in the purchase of health professions training equipment.

Deadline Note

The application due date in Grants.gov is March 26, 2010. The supplemental information due date in EHB's is April 26, 2010.

Synopsis

The sponsor is announcing the availability of funds to support multiple programs in the purchase of health professions training equipment.

Deadline Note

The application due date in Grants.gov is March 26, 2010. The supplemental information due date in EHB's is April 26, 2010.

Synopsis

The sponsor is announcing the availability of funds to support multiple programs in the purchase of health professions training equipment.

Deadline Note

The application due date in Grants.gov is March 26, 2010. The supplemental information due date in EHB's is April 26, 2010.

Synopsis

The sponsor is announcing the availability of funds to support multiple programs in the purchase of health professions training equipment.

Deadline Note

The application due date in Grants.gov is March 26, 2010. The due date in EHBs is April 9. 2010.

Synopsis

Health Center grants support a variety of community-based and patient-directed public and private nonprofit organizations and continue to serve an increasing number of the Nation’s underserved.

Synopsis

Under the leadership of the U.S. Global AIDS Coordinator, as part of the President's Emergency Plan, the U.S. Department of Health and Human Services’ Centers for Disease Control and Prevention (HHS/CDC) works with host countries and other key partners to assess the needs of each country and design a customized program of assistance that fits within the host nation's strategic plan and partnership framework. HHS/CDC focuses primarily on two or three major program areas in each country. Goals and priorities include the following: Achieving primary prevention of HIV infection through activities such as expanding confidential counseling and testing programs linked with evidence based behavioral change and building programs to reduce mother-to-child transmission; Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs) and related opportunistic infections by improving STI management; enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections, interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB); and initiating programs to provide anti-retroviral therapy (ART); Strengthening the capacity of countries to collect and use surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring and HIV screening for blood safety.

Synopsis

Under the leadership of the U.S. Global AIDS Coordinator, as part of the President's Emergency Plan, the U.S. Department of Health and Human Services’ Centers for Disease Control and Prevention (HHS/CDC) works with host countries and other key partners to assess the needs of each country and design a customized program of assistance that fits within the host nation's strategic plan and partnership framework. HHS/CDC focuses primarily on two or three major program areas in each country. Goals and priorities include the following: Achieving primary prevention of HIV infection through activities such as expanding confidential counseling and testing programs linked with evidence based behavioral change and building programs to reduce mother-to-child transmission; Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs) and related opportunistic infections by improving STI management; enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections, interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB); and initiating programs to provide anti-retroviral therapy (ART); Strengthening the capacity of countries to collect and use surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring and HIV screening for blood safety.

Deadline Note

Letters of Intent are not required to apply to this opportunity. If the applicant is interested in submitting a Letter of Intent, they are due on March 26, 2010. Applications are due on April 19, 2010.

Synopsis

The purpose of this grant activity is to fund demonstration projects for the development and establishment of systemic mechanisms and partnerships to enhance the prevention and treatment of sickle cell disease through coordination of service delivery, genetic counseling and testing, bundling of technical services, training of health professionals, and efforts related to the expansion and coordination of education, treatment, and continuity of care for individuals with sickle cell disease.

Synopsis

The purpose of the Partnership for Urban MCH Leadership Community Cooperative Agreement, as authorized by the Social Security Act, Title V, Section 501(a)(2) (42 USC 701), is to support a national membership organization focusing on urban maternal and child health (MCH) to assist its members to improve public health programs for the MCH population and the delivery of MCH services at the National, State, and local levels. This funding will assist in providing an effective link between the Maternal and Child Health Bureau (MCHB), urban MCH programs and officials, and MCH-related organizations at the National, State, and local levels.

Deadline Note

The deadline for receipt of optional letters of intent is February 18, 2010. The deadline for receipt of full applications is March 26, 2010.

Synopsis

The sponsor invites applications for Centers of Excellence in Molecular Hematology (CEMH). The Centers of Excellence in Molecular Hematology are part of an integrated program of hematologic diseases-related research support provided by the NIDDK. The Centers currently funded in this program have provided a focus for increasing collaboration and improving the cost-effectiveness of supported research among groups of successful investigators at institutions with an established, comprehensive hematologic diseases research base. An open competition is invited, in order to renew and strengthen this program.This FOA will utilize the P30 award mechanism.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after January 26, 2010. The deadlines for receipt of standard applications under this announcement are: January 25, May 25, and September 25 annually. The deadlines for receipt of AIDS-related applications are: January 7, May 7, and September 7 annually.This program will expire on January 8, 2013 .

Synopsis

The sponsor invites applications from applicant organizations that propose to create educational opportunities to attract undergraduate students, graduate students, and postdoctoral fellows to careers in areas of biomedical or behavioral research of particular interest to the NIDDK, while fostering the career development of these students and fellows. The NIDDK is especially interested in attracting students and postdoctoral fellows from scientific disciplines underrepresented in disease-oriented biomedical research, such as engineering, informatics, computer science, and computational sciences, to encourage them to apply their expertise to research relevant to diabetes and other endocrine and metabolic diseases; digestive and liver diseases; nutrition; obesity research and prevention; and kidney, urologic and hematologic diseases. This program will use the NIH Research Education (R25) grant mechanism.

Deadline Note

The deadline for receipt of optional letters of intent is March 26, 2010. The deadline for receipt of full applications is April 26, 2010.

Synopsis

The sponsor invites applications to examine the feasibility and value of generating a community resource of high quality, renewable affinity reagents for all human proteins. This specific FOA topic is focused on the production of proteins or peptides for the purpose of generating monoclonal antibodies that can be used in immunoprecipitation studies, and potentially for other affinity reagents, as well as broader uses by the scientific community and others. Thus, the FOA solicits projects that will provide the targeted proteins, peptides or other immunogens to other components of the pilot program (including a component that will generate monoclonal antibodies, to be solicited in FY2011), as well as to the wider community in the form of a renewable resource, e.g., clones or transfected cell lines. This FOA will prioritize human transcription factors as an initial set of targets. This FOA will utilize the U01 Research Project Cooperative Agreement.

Synopsis

The sponsor hereby announces its interest in receiving applications from interdisciplinary teams of Computer Science/Computer Engineering researchers in the areas of Advanced Architectures and Critical Technologies for Exascale Computing. Multi institutional applications with cohesive emphasis on transformational discoveries that address key barriers on the path to exascale computing are encouraged. Partnerships among academic institutions, National Laboratories, and industry are strongly encouraged.

Deadline Note

The deadline for receipt of optional letters of intent is March 27, 2010. The deadline for receipt of full applications is April 27, 2010.

Synopsis

The sponsors invite applications from institutions/organizations that propose to study the applicability of novel technologies and approaches towards the development and regulatory review of medical products (including drugs, biologics, and devices). This regulatory science initiative will foster the development, evaluation and availability of new or improved tools, methods, standards, and applied science that support a better understanding and improved evaluation of product safety, quality, effectiveness, and manufacturing throughout the product life cycle. This area of science has knowledge gaps that deserve special emphasis and would benefit from strategic coordination and planning by NIH and FDA. Advances in this area depend on the incorporation of cutting-edge science and evidence-based knowledge into regulatory decision making. Support through this FOA for regulatory science research will facilitate the translation of biomedical discoveries to improve prevention, treatment, and diagnosis of human health problems. This FOA will utilize the NIH Research Project Cooperative Agreement (U01).

Deadline Note

The deadline date for submission of applications is 11:59 p.m., Eastern Time, on March 29, 2010. Applicants are requested, but not required, to submit a letter of intent to apply for this funding opportunity to assist AoA in planning for the application independent review process. The deadline for submission of the letter of intent is February 26, 2010.

Synopsis

The Eldercare Locator assists older adults, their families and caregivers find their way through the maze of services for seniors by identifying trustworthy local support resources. The goal is to provide users with the information and resources they need that will help older persons live independently and safely in their homes and communities for as long as possible.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after March 1, 2010. This program will expire on January 8, 2013.

Synopsis

The sponsor invites applications for extramural health services research, demonstration, dissemination, and evaluation grants that propose to prevent and more effectively manage healthcare associated infections (HAIs). HAIs are infections that patients acquire during the course of receiving treatment for other conditions within any healthcare setting. HAIs exact a significant toll on human life, are among the leading causes of preventable death in the United States, and accounted for an estimated 1.7 million infections and 99,000 associated deaths in 2002. In addition to the substantial human suffering caused by HAIs, the financial burden attributable to such infections is staggering. It is estimated that HAIs result in $28 to $33 billion in excess healthcare costs each year. Research priorities for this FOA are the: 1) development, implementation and demonstration of the prevention and management of HAIs, along with the determination of the costs of such interventions; 2) determination of the efficacy, effectiveness, and costs of preventative interventions; 3) population-level studies on the patient risk factors, clinical presentation, sources, and disease genotypes of antibiotic-resistant organisms that can result in perceived HAIs. The scientific and practical knowledge to be achieved through these research and demonstration efforts will identify the practical and cost-effective approaches to preventing and managing HAIs. This funding opportunity announcement (FOA) solicits Research Demonstration (R18) Projects.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after February 28, 2010. The deadline for receipt of full applications is March 29, 2010.

Synopsis

The sponsor invites Research Project Grant (R01) applications from organizations that propose to develop the infrastructure and improve the methodology for collecting prospective data from electronic clinical databases to generate new evidence on the comparative effectiveness of healthcare interventions. This FOA will use the AHRQ Research Project Grant (R01) mechanism.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after February 28, 2010. The deadline for receipt of full applications is March 29, 2010.

Synopsis

The sponsor, supported by funds provided to AHRQ under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, invites infrastructure development research grant (R01) applications from organizations seeking to either 1) enhance the clinical content of statewide, all-payer, hospital-based encounter-level data to support comparative effectiveness research, or 2) improve the reliability and validity of information in hospital-based encounter-level data related to race and ethnicity. This FOA will use the AHRQ Research Project (R01) grant mechanism.

Deadline Note

This announcement will remain open until 30 September 2011. White Papers may be submitted at any time during this period. Up to three evaluations of White Papers received will take place while the announcement is open. Once notified that a full proposal is not desired from a White Paper, resubmission of the same White Paper is strongly discouraged. The actual number of evaluations will depend upon the availability of funds. The submission date for the first evaluation cycle is 3/29/2010.

Synopsis

The DoD HIV/AIDS Prevention Program (DHAPP), based at the Naval Health Research Center (NHRC) in San Diego, California, provides technical assistance, management, and administrative support of the global HIV/AIDS prevention, care, and treatment for foreign militaries. DHAPP administers funding, conducts training, and provides technical assistance to participating militaries. This BAA is intended to solicit existing partners and establish new partners in order to expand the DHAPP program.

Synopsis

The purpose of this cooperative agreement is to support and expand the functions of a National Fetal and Infant Mortality Review (NFIMR) resource center.

Deadline Note

Optional letters of intent are due on March 29, 2010. Full applications are due on paril 26, 2010.

Synopsis

The sponsor will provide support for research to determine the effectiveness of empiric influenza antiviral therapy, in addition to empiric antibiotic therapy, for hospitalized CAP patients during the periods when influenza viruses are circulating in the community; data from all funded sites will be collected in such a way to allow for pooling of data. The recent identification in April, 2009 and subsequent global spread of a novel influenza virus, novel influenza A (H1N1), makes this an ideal time to conduct such studies.

Deadline Note

Optional letters of intent are due on March 29, 2010. Full applications are due on April 29, 2010.

Synopsis

The purpose of this announcement is to solicit applications from applicant organizations that target one or more modifiable risk factors for suicidal behavior with a primary prevent strategy that is designed to enhance connectedness and to rigorously assess the efficacy or effectiveness of that strategy.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after March 26, 2010. The deadline for receipt of optional letters of intent is March 29, 2010. The deadline for receipt of full applications is April 26, 2010.

Synopsis

The sponsor invites applications that will improve understanding of the basic mechanisms of behavior change by bridging work in the laboratory and the field. This understanding will advance several goals, including: the identification of the optimal targets and timepoints in the lifecourse for intervention; the identification of common mechanisms of change related to either multiple or bundled health behaviors; the ability to tailor interventions to particular at-risk individuals or groups; the application of novel technologies for behavioral assessment and change; and the identification of individuals or groups most likely to benefit from specific interventions. This initiative seeks to establish the groundwork for a unified science of behavior change, capitalizing on emerging basic science to accelerate investigation of common mechanisms that play a role in initiating or maintaining behavior change and are applicable across a broad range of health-related behaviors. Approaches from behavioral economics; the social, behavioral, cognitive and affective neurosciences; neuroeconomics; behavior genetics and genomics; and systems science are specifically encouraged. By focusing basic research on the mechanisms of behavior change, and by integrating work across laboratory and field contexts, this initiative should transform the efficacy, effectiveness, and cost efficiency of behavior change interventions. This FOA will use the NIH Research Project (R01) award mechanism.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after March 29, 2010. The deadline for receipt of optional letters of intent is March 29, 2010. The deadline for receipt of full applications is April 29, 2010.

Synopsis

The sponsor invites applications utilizing systems biology approaches to interrogate and integrate multiple complex databases in order to discover new paradigms that may lead to unanticipated avenues of research at the interface of HIV/AIDS and substance use and abuse. This FOA will utilize the R01 award mechanism.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after March 29, 2010. The deadline for receipt of optional letters of intent is March 29, 2010. The deadline for receipt of full applications is April 29, 2010.

Synopsis

The sponsor invites applications to support a diverse array of preclinical and/or clinical research projects that accelerate the translational discovery/development of safe and effective medications for the treatment of substance-related disorders (SRDs), with the ultimate goal of moving closer to, or gaining FDA approval of medications for the treatment of these disorders. This FOA will use the NIH Research Project (R01) award mechanism.

Synopsis

The sponsor's program focuses on innovation and operations research (OR) in delivery strategies for high impact maternal, newborn, and child health (MNCH) interventions. In addition, the RFA is seeking to attract new partners to contribute to innovation and expand and improve the capacity of partners to contribute to the Stop Tuberculosis (TB) strategy interventions in targeted countries to meet global TB targets. The CSHGP’s focus on innovation continues to strengthen a major shift in the program and in the criteria for selecting grantees and is closely aligned with the GH Bureau’s mandate for innovation and technical leadership.

Synopsis

Under the leadership of the U.S. Global AIDS Coordinator, as part of the President's Emergency Plan, the U.S. Department of Health and Human Services’ Centers for Disease Control and Prevention (HHS/CDC) works with host countries and other key partners to assess the needs of each country and design a customized program of assistance that fits within the host nation's strategic plan and partnership framework. HHS/CDC focuses on two or three major program areas in each country. Goals and priorities include the following: Achieving primary prevention of HIV infection through activities such as expanding confidential counseling and testing programs linked with evidence based behavioral change and building programs to reduce mother-to-child transmission; Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs) and related opportunistic infections by improving STI management, enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections, interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB), and initiating programs provide anti-retroviral therapy (ART); Strengthening the capacity of countries to collect and use surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring and HIV screening for blood safety.

Synopsis

Under the leadership of the U.S. Global AIDS Coordinator, as part of the President's Emergency Plan, the U.S. Department of Health and Human Services’ Centers for Disease Control and Prevention (HHS/CDC) works with host countries and other key partners to assess the needs of each country and design a customized program of assistance that fits within the host nation's strategic plan and partnership framework. HHS/CDC focuses on two or three major program areas in each country. Goals and priorities include the following: Achieving primary prevention of HIV infection through activities such as expanding confidential counseling and testing programs linked with evidence based behavioral change and building programs to reduce mother-to-child transmission; Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs) and related opportunistic infections by improving STI management; enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections; interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB); and initiating programs to provide anti-retroviral therapy (ART); Strengthening the capacity of countries to collect and use surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring and HIV screening for blood safety.

Synopsis

Under the leadership of the U.S. Global AIDS Coordinator, as part of the President's Emergency Plan, the U.S. Department of Health and Human Services’ Centers for Disease Control and Prevention (HHS/CDC) works with host countries and other key partners to assess the needs of each country and design a customized program of assistance that fits within the host nation's strategic plan and partnership framework. HHS/CDC focuses primarily on two or three major program areas in each country. Goals and priorities include the following: Achieving primary prevention of HIV infection through activities such as expanding confidential counseling and testing programs linked with evidence based behavioral change and building programs to reduce mother-to-child transmission; Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs) and related opportunistic infections by improving STI management; enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections, interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB); and initiating programs to provide anti-retroviral therapy (ART); Strengthening the capacity of countries to collect and use surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring and HIV screening for blood safety.

Synopsis

PRM will prioritize currently available funding for proposed NGO activities that best meet the Bureau’s priorities for Tibetan refugees as identified below: (a) Proposed activities should primarily support Tibetan refugees in India, Nepal, and, to a lesser extent, Bhutan. (b) Proposals may include work in one or more the following sectors: protection; reception facilities; health care and technical assistance; nutrition; water and sanitation; shelter; education; vocational training; and livelihoods development.

Deadline Note

Optional letters of intent are due on March 30, 2010. Full applications are due on April 30, 2010.

Synopsis

The sponsor invites applications for cooperative agreements to support the development of training and education programs for workers engaged in mining operations in the Western United States. The major objective of this solicitation is to reduce the number of injuries and illnesses among workers who are involved in mining operations through a focused, relevant, and comprehensive training program that educates mine workers regarding how best to protect themselves from risks and hazards in the mining environment, and that expands the number of qualified mine safety and health trainers in the U.S.

Deadline Note

The deadline for receipt of optional letters of intent is March 30, 2010. The deadline for receipt of full applications is April 30, 2010.

Synopsis

The sponsors invite cooperative agreement grant applications from institutions/organizations that propose to develop a redesigned and enhanced Parkinson’s Disease Data Organizing Center. NINDS and NIEHS are committed to facilitating the collection and sharing of data related to clinical and translational research in Parkinson’s disease. The goal of this program is a resource that will serve the Parkinson’s disease (PD) research community by developing an ongoing repository for data from clinical trials and clinical studies, including epidemiologic and genetic studies, related to PD, and sharing of these data to enhance research. These data may include clinical as well as associated imaging, genetic, and neuropathology data elements. In addition, the Center will link clinical data with associated genetic, biospecimen, imaging, and neuropathology data as available in other databases. The Parkinson’s Disease Data Organizing Center also will develop a flexible web-based data entry system using standardized common data elements for PD clinical research studies that can be modified by investigators for a variety of clinical research studies. The center will also maintain an up-to-date listing of resources for researchers in the scientific community. Ongoing outreach efforts should be undertaken to maximize data sharing via this resource in order to optimize research in PD. The information technology employed should serve to optimize the accessibility and usefulness of the information within the data organizing center.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after March 30, 2010. The deadline for receipt of optional letters of intent is March 30, 2010. The deadline for receipt of full applications is April 30, 2010.

Synopsis

The sponsor invites applications for research studies that focus on the identification, and preclinical and clinical evaluation, of medications that can be safe and effective for the treatment of cannabis-use and -induced disorders, as well as their medical and psychiatric consequences. The studies can be preclinical or FDA-defined Phase I, Phase II or Phase III clinical trials. This FOA will use the NIH Research Project (R01) award mechanism.

Deadline Note

Applicants are required to submit a Letter of Intent (LOI) to be eligible to apply for this program and must be received by March 30, 2010. Applications must be received electronically by April 19, 2010.

Synopsis

This notice announces the availability of $10 million as part of the Communities Putting Prevention to Work (CPPW) initiative for National Organizations to work in partnership with communities to achieve the following goals: increase levels of physical activity; improve nutrition (e.g. increase fruit/vegetable consumption, reduce salt and transfats); decrease overweight/obesity prevalence; (4) decrease smoking prevalence and teen smoking initiation; and decrease exposure to second-hand smoke.

Synopsis

The sponsor is inviting applications for a collaborative project to strengthen civil society organizations (CSOs) in Tanzania and Zanzibar in an effort to combat HIV and AIDS. The sponsor will provide an award of $10,000,000 over five years.

Deadline Note

<p>Applications may be submitted to Grants.gov in response to this announcement on or after February 18, 2010 (passed). The deadline for receipt of full applications is March 31, 2010.</p>

Synopsis

The sponsor, supported by funds provided to AHRQ under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA”), Public Law 111-5, invites Research Project Grant (R01) applications from investigators seeking to conduct rigorous comparative evaluations of alternative system designs, change strategies, and interventions that have already been implemented in healthcare and are likely to improve quality and other outcomes. This FOA will use the AHRQ Research Project (R01) award mechanism.

Synopsis

Title VII of the Public Health Service (PHS) Act, Section 766, authorizes the Secretary to issue awards for the operation of PHTCs to accredited schools of public health, or other public or nonprofit private institutions accredited for the provision of graduate or specialized training in public health.

Synopsis

Under the leadership of the U.S. Global AIDS Coordinator, as part of the President's Emergency Plan, the U.S. Department of Health and Human Services’ Centers for Disease Control and Prevention (HHS/CDC) works with host countries and other key partners to assess the needs of each country and design a customized program of assistance that fits within the host nation's strategic plan and partnership framework. HHS/CDC focuses on two or three major program areas in each country. Goals and priorities include the following: Achieving primary prevention of HIV infection through activities such as expanding confidential counseling and testing programs linked with evidence based behavioral change and building programs to reduce mother-to-child transmission; Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs) and related opportunistic infections by improving STI management, enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections, interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB), and initiating programs provide anti-retroviral therapy (ART); Strengthening the capacity of countries to collect and use surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring and HIV screening for blood safety.

Synopsis

A -- BROAD AGENCY ANNOUNCEMENT BASIC AND APPLIED RESERACH AT THE U.S. ARMY NATICK SOLDIER RESERACH, DEVELOPMENT AND ENGINEERING CENTER, NATICK, MA SOL W911QY-09-11 DUE 033110 POC Darlene Rideout, (508) 233-4125 POP RDECOM Acquisition Center - Natick ATTN: AMSRD-ACC-N, Natick Contracting Division (R and BaseOPS), Building 1, Kansas Street Natick MA 01760-5011 WEB: FedBizOpps Complete View https://www.fbo.gov/?s=opportunity&mode=form&id=76d07b9159429a0f2a4d5f536537ae23&tab=core&_cview=1 THERE ARE NO FUNDS AGAINST THE BAA SOLICITATION. GO TO THE FOLLOWING WEB SITE UNDER BUSINESS OPPORTUNITIES TO VIEW THE ENTIRE BAA SOLICITATION FOR FULL DETAILS: https://www3.natick.army.mil The U.S. Army Natick Soldier Research, Development and Engineering Center Broad Agency Announcement (BAA) identifies scientific and technical areas of interest for research and/or exploratory development. This BAA is conducted using full and open competition. In an effort to minimize proposal preparation cost,this BAA utilizes a two-step process. The first step will be the submission of a concept paper. Offerors that submit concept papers that are consistent with the intent of the BAA, and are of interest to the government will be invited to submit a proposal (step two). Such an invitation does not assure that the submitting organization will be awarded a contract. Instructions for the submission of concept papers and proposals are contained in the BAA. The submission of a concept paper is required prior to the submission of a proposal. Failure to follow this two-step process may preclude the chance for award. Proposals submitted in response to the BAA will be evaluated in accordance with the evaluation criteria set forth in the BAA. Technical evaluations will employ a peer or scientific review process. A proposal's technical evaluation, and its importance to agency programs, along with funding availability are primary bases for contract award. Cost realism and reasonableness shall also be considered to the extent appropriate. Concept papers will be accepted continuously through 28 February 2011. This BAA will remain open continuously through 31 March 2011. The BAA technical areas of interest are divided into the following groups: 1. Combat Feeding Equipment and Systems (objectives focus on combat food service equipment for individual and group feeding, and unit/organization equipment); 2. Combat Ration Research and Development; 3. Warrior Systems Technologies (objectives focus on ballistic protection for individuals, integrated protective helmet, modular personnel protection system (MPPS), chemical/biological protection for individuals, flame and thermal protection for the individual soldier, countersurveillance, body worn interactive materials, body-worn systems, hand held devices, and smart-lightweight electronic components/modules for soldier protection, knowledge management and cognitive improvement, biomechanics, materials nanotechnology, lightweight conformal solar cells, anthropometry, advanced protection and integration technologies and systems, warrior performance and soldier-borne power source); 4. Tentage, Fabric Structures and Rigid Wall Shelters; 5. Airdrop - Advanced Personnel and Cargo Airdrop Systems; 6. Textile Technologies; 7. Modeling and Simulation (objectives focus on individual and small unit performance and survivability, and wargaming concept and tool development); 8. Neuroepidemiology; 9. National Protection Center; 10. Warfighter Advanced Technologies). All technical questions may be directedto the respective technical/administrative POC listed under each technical areaof interest on the BAA. CITE: https://www.fbo.gov/?s=opportunity&mode=form&id=76d07b9159429a0f2a4d5f536537ae23&tab=core&_cview=0 Posted 03/31/09 (W-SN01781480). (0090) (kww)

Deadline Note

Investigators must first submit a pre-application. Pre-applications are due by 5:00 p.m. Eastern time, March 31, 2010. Selected applicants will be invited to submit full proposals. If invited, full proposals are due by 11:59 p.m. Eastern time, July 28, 2010.

Synopsis

The goal of the FY10 ARP is to improve the lives of individuals living with autism spectrum disorders now. The ARP challenges the scientific community to design high-impact, innovative research that will foster new directions for and address neglected issues in the field of ASD research. The ARP focuses its funding on innovative projects that have the potential to make a significant impact on the lives of individuals with ASD. The ARP Idea Award supports high-impact, innovative research that advances the understanding of ASD and leads to improved quality of life for individuals with ASD.

Deadline Note

A letter of intent should be submitted by March 31, 2010. Proposals are due June 25, 2010.

Synopsis

The Tuberous Sclerosis Complex Research Program (TSCRP) Clinical Research Award supports TSC research projects performed by clinical researchers involved in the support of clinical care of individuals with TSC. Proposed research should have a direct link to TSC clinical outcomes.

Deadline Note

Pre-applications must be submitted by 5:00 p.m. Eastern time, March 31, 2010. Selected applicants will be invited to submit a full proposal. If invited, full proposals are due 11:59 p.m. Eastern time, July 28, 2010.

Synopsis

The goal of the FY10 ARP is to improve the lives of individuals living with autism spectrum disorders now. The ARP challenges the scientific community to design high-impact, innovative research that will foster new directions for, and address neglected issues in, the field of ASD research. The ARP focuses its funding on projects that have the potential to make a significant impact on the lives of individuals with ASD. The ARP CTA supports clinical trials with the potential to have a major impact on the treatment or management of ASD.

Deadline Note

Investigators must first submit a pre-application. Pre-applications are due by 5:00 p.m. Eastern time, March 31, 2010. Selected applicants will be invited to submit full proposals. If invited, full proposals are due by 11:59 p.m. Eastern time, July 28, 2010.

Synopsis

The goal of the FY10 ARP is to improve the lives of individuals living with autism spectrum disorders now. The ARP challenges the scientific community to design high-impact, innovative research that will foster new directions for and address neglected issues in the field of ASD research. The ARP focuses its funding on innovative projects that have the potential to make a significant impact on the lives of individuals with ASD. The ARP Idea Award supports high-impact, innovative research that advances the understanding of ASD and leads to improved quality of life for individuals with ASD.

Synopsis

The sponsor provides funding for developing and implementing outreach and partnership programs that inform and educate the public about indoor air quality and actions that can reduce potential risks in homes, schools, and workplaces. Through these programs, the sponsor disseminates information and works with state, tribal and local governments; industry and professional groups; and the public to promote actions to reduce exposures to possibly harmful levels of indoor pollutants. Awards range from $5,000 to $50,000 and are from twelve to twenty-four months.

Synopsis

The sponsor provides funding to identify and disseminate information about exemplary and effective alcohol or other drug abuse prevention programs implemented on college campuses. Through this grant program, the U.S. Department of Education (ED) also will recognize colleges and universities whose programs, while not yet exemplary or effective, show evidence that they are promising.

Synopsis

The sponsor proposes to enter into a Cooperative Agreement for the implementation of Tuberculosis CARE (TB CARE). This activity falls under President Obama’s Global Health Initiative (GHI), which focuses attention on tackling broader global health challenges, continuing the support for HIV/AIDS and malaria, and increasing support for TB, child and maternal health, family planning, and neglected tropical diseases.

Synopsis

Under the leadership of the U.S. Global AIDS Coordinator, as part of the President's Emergency Plan, the U.S. Department of Health and Human Services’ Centers for Disease Control and Prevention (HHS/CDC) works with host countries and other key partners to assess the needs of each country and design a customized program of assistance that fits within the host nation's strategic plan and partnership framework. HHS/CDC focuses on two or three major program areas in each country. Goals and priorities include the following: Achieving primary prevention of HIV infection through activities such as expanding confidential counseling and testing programs linked with evidence based behavioral change and building programs to reduce mother-to-child transmission; Improving the care and treatment of HIV/AIDS, sexually transmitted infections (STIs) and related opportunistic infections by improving STI management; enhancing laboratory diagnostic capacity and the care and treatment of opportunistic infections; interventions for intercurrent diseases impacting HIV infected patients including tuberculosis (TB); and initiating programs to provide anti-retroviral therapy (ART); Strengthening the capacity of countries to collect and use surveillance data and manage national HIV/AIDS programs by expanding HIV/STI/TB surveillance programs and strengthening laboratory support for surveillance, diagnosis, treatment, disease monitoring and HIV screening for blood safety.

Deadline Note

The sponsor requests, although does not require, a brief notice of intent to apply by April 1, 2010. Full proposals are due on May 14, 2010.

Synopsis

This solicitation provides for the continuation of the work of the National Polar-Orbiting Operational Environmental Satellite System (NPOESS) Preparatory Project (NPP). The NPP is the first satellite mission to address the challenge of accumulating long-term, high-accuracy, stable, environmental observations that are essential to document the state of the global Earth system as well as past and future variability and changes within it.

Deadline Note

Optional letters of intent are due on April 1, 2010. Full applications are due on May 3, 2010.

Synopsis

The sponsor will provide funding for research to describe the long-term audiologic, visual, developmental, cognitive, motor and somatic/growth differences among children born with 1) symptomatic cytomegalovirus (CMV) infection, 2) congenital CMV infection that is asymptomatic at birth, and 3) children uninfected with CMV at birth.

Deadline Note

The deadline for receipt of optional letters of intent is April 2, 1010. The deadline for receipt of full applications is April 27, 2010.

Synopsis

This FOA seeks to establish a pilot-scale data production effort to systematize approaches for identifying mechanism-based associations among the effects of disparate biological perturbations, a knowledge base that can be used to study functional relationships among the responding cellular components. The Library of Integrated Network-Based Cellular Signatures (LINCS) program will support the high-throughput collection and integrative computational analysis of informative molecular activity and cellular feature signatures generated in response to a variety of perturbing agents, including siRNAs and small bioactive molecules, which are applied to a set of carefully selected cell types. The resulting knowledge will form the basis of a long-lived resource that can be used broadly by the community. For example LINCS may inform association of disease states with detailed molecular or cellular phenotypes, and ultimately associate disease with specific gene networks, or inform the mechanism of action of known drugs. This FOA seeks to fund pilot-scale data production efforts that will produce a usable initial resource while addressing the following issues: optimization of methods, integration of data, and scalability. Pilot production efforts will interact with multiple future additional components (data analysis and informatics tools; and development and integration of new production-ready technologies) of the LINCS program. This Funding Opportunity Announcement (FOA) is developed as a Common Fund initiative (http://commonfund.nih.gov/) through the NIH Office of the NIH Director, Office of Strategic Coordination (http://dpcpsi.nih.gov/osc/). This FOA will be administered by the National Human Genome Research Institute (NHGRI) and the National Heart Lung and Blood Institute (NHLBI) on behalf of the NIH. This FOA will utilize the U54 specialized centers cooperative agreement award mechanism.

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after July 3, 2009. The deadlines for receipt of optional letters of intent are: July 3, 2009; November 3, 2009; and March 1, 2010. The deadlines for receipt of full applications are: August 3, 2009; December 3, 2009; and April 1, 2010.

Synopsis

The sponsor solicits applications that propose to conduct time-sensitive ancillary studies related to the NIAMS mission in conjunction with privately or publicly funded, large, ongoing clinical projects. The ongoing “parent” project can be a large clinical trial or observational study, or a disease registry that can provide a sufficient cohort of well-characterized patients, infrastructure, data, and biological samples. Applications submitted in response to this FOA will undergo an accelerated review and award process. Each application must include a timeline to demonstrate that the parent project has adequate time left to accommodate the proposed ancillary study. In addition, it must justify the time-sensitive nature of the ancillary study and the need for an expedited review and award process. It must also document permission from the parent project to use the patient cohorts, data, and biological materials. The objective of this FOA is to provide a flexible mechanism to leverage established resources and maximize the return on existing investments in parent projects. Successful ancillary studies will enhance the scientific content and value of the parent projects, improve the research community’s understanding of a disease or organ system in the NIAMS portfolio, and thus identify novel targets for diagnosis, treatment, and prevention of disease. This FOA will use the NIH Research Project (R01) award mechanism.